We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look ...

CHICAGO, April 01, 2025--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA" or the "Company"), a clinical-stage biopharmaceutical company ...

“MAIA continues to bring innovation to the biotech industry as one of the earliest pioneers of telomere targeting as a strategy for cancer treatment. Our lead candidate is THIO (ateganosine ...

MAIA Biotechnology, Inc., ("MAIA" or the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today published a 2025 Shareholder Letter by CEO Vlad ...

MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA – Free Report) – Diamond Equity raised their Q1 2025 EPS estimates for MAIA Biotechnology in a report issued on Tuesday, March 25th.

Investors might want to bet on MAIA Biotechnology, Inc. (MAIA), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

In this article, we are going to take a look at where MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) stands against other cheapest stocks insiders are buying in March. After solid gains Monday ...

In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Unicycive Therapeutics (UNCY – Research Report), ...

Interstitial lung disease (ILD) represents a diverse group of disorders characterized by infiltration of lung parenchyma with extracellular matrix, leading to progressive respiratory impairment and ...